DOCSLIB.ORG

Trna M7g Methyltransferase Trm8p/Trm82p: Evidence Linking Activity to a Growth Phenotype and Implicating Trm82p in Maintaining Levels of Active Trm8p

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Trna M7g Methyltransferase Trm8p/Trm82p: Evidence Linking Activity to a Growth Phenotype and Implicating Trm82p in Maintaining Levels of Active Trm8p Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press tRNA m7G methyltransferase Trm8p/Trm82p: Evidence linking activity to a growth phenotype and implicating Trm82p in maintaining levels of active Trm8p ANDREI ALEXANDROV, ELIZABETH J. GRAYHACK, and ERIC M. PHIZICKY Department of Biochemistry and Biophysics, University of Rochester School of Medicine, Rochester, New York 14642, USA ABSTRACT We show that Saccharomyces cerevisiae strains lacking Trm8p/Trm82p tRNA m7G methyltransferase are temperature-sensitive in synthetic media containing glycerol. Bacterial TRM8 orthologs complement the growth defect of trm8-⌬, trm82-⌬, and trm8-⌬ trm82-⌬ double mutants, suggesting that bacteria employ a single subunit for Trm8p/Trm82p function. The growth phenotype of trm8 mutants correlates with lack of tRNA m7G methyltransferase activity in vitro and in vivo, based on analysis of 10 mutant alleles of trm8 and bacterial orthologs, and suggests that m7G modification is the cellular function important for growth. Initial examination of the roles of the yeast subunits shows that Trm8p has most of the functions required to effect m7G modification, and that a major role of Trm82p is to maintain cellular levels of Trm8p. Trm8p efficiently cross-links to pre- tRNAPhe in vitro in the presence or absence of Trm82p, in addition to its known residual tRNA m7G modification activity and its SAM-binding domain. Surprisingly, the levels of Trm8p, but not its mRNA, are severely reduced in a trm82-⌬ strain. Although Trm8p can be produced in the absence of Trm82p by deliberate overproduction, the resulting protein is inactive, suggesting that a second role of Trm82p is to stabilize Trm8p in an active conformation. Keywords: tRNA modification; S. cerevisiae; S-adenosylmethionine; methyltransferases; Trm8; Trm82; YggH; TM0925; 7-methylguanosine; m7G INTRODUCTION Gcd14p (Anderson et al. 1998), I34 adenosine deaminase Tad2p/Tad3p (Gerber and Keller 1999), and tRNAHis G A continuing puzzle in RNA biology is the precise role of −1 guanylyltransferase Thg1p (Gu et al. 2003). Strains lacking tRNA modifications. Although more than 79 different each of six other modification enzymes affecting residues in modifications have been identified in tRNA (Limbach et al. the anticodon region have distinct growth or translation 1994; Bjork 1995), and 25 of these modifications are found phenotypes, including 2Ј-O-Me methyltransferase in yeast (Sprinzl et al. 1998), a cellular role for many of 32,34 Trm7p (Pintard et al. 2002), m1G /m1I methyltransfer- them has not yet been defined. The recent identification of 37 37 ase Trm5p (Bjork et al. 2001), ⌿ pseudouridylase a substantial number of genes responsible for tRNA modi- 38,39 Pus3p (Lecointe et al. 1998), mcm5U/mcm5s2U carboxyl fication (Hopper and Phizicky 2003) has allowed the op- 34 methyltransferase Trm9p (Kalhor and Clarke 2003), portunity to study their roles by examining mutant pheno- m5C methyltransferase Trm4p (Wu et al. 1998), types. 34,40,48,49 and i6A isopentenyl transferase Mod5p (Laten et al. 1978; Surprisingly, deletion of the majority of enzymes respon- 37 Janner et al. 1980; Dihanich et al. 1987). sible for tRNA modification revealed few obvious defects. The other 16 known modification enzymes in yeast each Only three tRNA modifying enzymes in yeast are known to modify residues remote from the anticodon region, and be essential, including m1A methyltransferase Gcd10p/ 58 mutants lacking these enzymes have only subtle pheno- types. Each of these mutants has little obvious growth or Reprint requests to: Eric Phizicky, Department of Biochemistry and translation defect, and the observation of distinct pheno- Biophysics, University of Rochester School of Medicine, 601 Elmwood types has required more sensitive approaches such as syn- Ave., Box 712, Rochester, NY 14642, USA; e-mail eric_phizicky@ thetic interaction screens (Grosshans et al. 2001; Johansson urmc.rochester.edu. Article published online ahead of print. Article and publication date are and Bystrom 2002; Urbonavicius et al. 2002), or, as shown at http://www.rnajournal.org/cgi/doi/10.1261/rna.2030705. in Escherichia coli, growth competition experiments (Gutg- RNA (2005), 11:821–830. Published by Cold Spring Harbor Laboratory Press. Copyright © 2005 RNA Society. 821 Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Alexandrov et al. sell et al. 2000). The lack of obvious phenotype of strains Aquifex aeolicus aq065 protein purified from E. coli (Oka- lacking these modification enzymes contrasts sharply with moto et al. 2004). the strong evolutionary conservation of a number of these As a first step toward determining the physiological roles enzymes and their modifications. Even more unexpectedly, of TRM8/TRM82 genes and the role of m7G modification of some of the subtle phenotypes associated with defects in tRNA, we have found and characterized a phenotype asso- 5 tRNA modification, including those of yeast m U54 meth- ciated with loss of either or both of the TRM8 and TRM82 yltransferase Trm2p (Johansson and Bystrom 2002) and E. genes. We show that this growth phenotype is strongly cor- ⌿ 7 coli 55 pseudouridylase TruB (Gutgsell et al. 2000), were related with m G methyltransferase activity in vitro and in complemented with catalytically inactive mutants, suggest- vivo. We also provide in vivo evidence that the bacterial ing that lack of the modification of tRNA is not the cause of Trm8 ortholog does not require a second subunit to func- the defect, and that tRNA-modifying enzymes may have tion in yeast, raising the issue of the function of each of the other distinct cellular roles. two yeast subunits. We focus here on m7G (7-methylguanosine) modifica- We provide evidence that a crucial function of yeast tion of tRNA. This modification is highly conserved, based Trm82p is to maintain the levels of active Trm8p in vivo, on its presence in >40% of all sequenced bacterial and since deletion of Trm82p results in a severe reduction in the eukaryotic tRNA species. In all but three cases, m7Gis level of Trm8p protein, and Trm8p prepared from yeast in found at position 46 in the extra loop, a site known from the absence of Trm82p is not detectably active. In contrast, the crystal structures of tRNAPhe (Kim et al. 1974; Robertus Trm8p appears to possess the requisite functions of the Met et al. 1974) and tRNAi (Basavappa and Sigler 1991) to catalytic subunit: it has a SAM-binding domain, has re- form tertiary interactions with bases at positions 13 and 22. sidual catalytic activity when purified from E. coli, and Additionally, the m7G and m1A modification are the only cross-links to pre-tRNAPhe in vitro. two yeast modifications that confer a positive charge to the base. We previously used a biochemical genomics approach to RESULTS identify two proteins, Trm8p and Trm82p, that copurify with tRNA m7G methyltransferase activity. We showed that TRM8 and TRM82 are both required for growth at 7 these two proteins are both necessary for m G46 modifica- 38°C on glycerol-containing synthetic media tion of tRNA in vivo and in vitro, form a complex in vivo, We found a distinct growth defect that results from the loss and are sufficient for activity in vitro (Alexandrov et al. of TRM8 or TRM82 genes. As demonstrated in Figure 1 by 2002). Neither Trm8p nor Trm82p is significantly related to 7 serial 10-fold dilutions of yeast cells, homozygous diploid yeast Abd1p, which catalyzes m G formation during cap- strains lacking either Trm8p (relevant genotype: trm8-⌬/ ping of mRNAs (Mao et al. 1995), other than within the trm8-⌬) or Trm82p (relevant genotype: trm82-⌬/trm82-⌬) S-adenosylmethionine (SAM)-binding domain of Trm8p. grow extremely poorly relative to wild-type strains on syn- Trm8p is highly conserved in eukaryotes and bacteria, ex- thetic minimal media (Sherman 1991) containing 2% glyc- tending from humans to Mycoplasma genitalium, with less erol at 38°C. No obvious growth differences were observed that 500 ORFs (Bahr et al. 1999), and Trm82p orthologs are between mutants and the wild-type strain on this media at present in the majority of sequenced eukaryotes. Neverthe- 30°Corat36°C, or on two other media at either 30°Cor less, deletion of TRM8 or TRM82 results in no obvious growth defect under standard laboratory conditions (Alex- androv et al. 2002), raising the question of the role of these proteins in these organisms. Surprisingly, whereas Trm8p/Trm82p complex appears to be conserved in eukaryotes, it may be a single Trm8p subunit in bacteria, since bacteria appear to lack Trm82p (Michaud et al. 2000). We showed previously that the two- protein mechanism of tRNA m7G formation is conserved in higher eukaryotes, since expression of both human ortholo- gous proteins (METTL1 and WDR4) in yeast was required to restore m7G methyltransferase activity in extracts (Alex- FIGURE 1. Growth defect of trm8-⌬/trm8-⌬ and trm82-⌬/trm82-⌬ androv et al. 2002). However, it appears that a single bac- strains on glycerol-containing minimal media. Homozygous diploid terial protein may be sufficient for activity, consistent with trm8-⌬/trm8-⌬, trm82-⌬/trm82-⌬, or wild-type strains, containing a the implication of a single purified 25-kDa Salmonella ty- CEN URA3 plasmid bearing TRM8 or TRM82 under control of its own phimurium polypeptide in tRNA m7G methylation (Col- promoter as indicated, were grown overnight, and 10-fold serial dilu- 7 tions were plated on synthetic media lacking uracil. (A) Cells plated on onna et al. 1983), and the demonstration of tRNA m G- glucose-containing media, incubated for2dat30°C. (B) Cells plated modifying activity for E. coli YggH (De Bie et al. 2003), and on glycerol-containing media, incubated for7dat38°C. 822 RNA, Vol. 11, No. 5 Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press tRNA m7G methyltransferase activity and phenotype 38°C: synthetic minimal media containing 2% dextrose, and pendence of the growth defects of trm8-⌬ and trm82-⌬ yeast extract-peptone media containing 2% glycerol (data strains, and the absence of an additional effect in the trm8-⌬ not shown).
Load more

Recommended publications
  • METTL1 Promotes Let-7 Microrna Processing Via M7g Methylation
    Article METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation Graphical Abstract Authors Luca Pandolfini, Isaia Barbieri, Andrew J. Bannister, ..., Mara d’Onofrio, Shankar Balasubramanian, Tony Kouzarides Correspondence [email protected] In Brief Pandolfini, Barbieri, et al. show that a subgroup of tumor suppressor microRNAs, including let-7e, contain 7-methylguanosine (m7G). Methyltransferase METTL1 is required for m7G modification of miRNAs, their efficient processing, and the inhibition of lung cancer cell migration. Structurally, m7G in miRNA precursors antagonizes RNA secondary structures that would otherwise inhibit their maturation. Highlights Data Resource d Internal m7G is identified in miRNAs by two independent GSE112182 sequencing techniques GSE112180 GSE112181 d Methyltransferase METTL1 mediates m7G modification of GSE120454 specific miRNAs GSE120455 d METTL1 promotes miRNA maturation and suppresses lung cancer cell migration d m7G promotes processing by antagonizing G-quadruplex structures in miRNA precursors Pandolfini et al., 2019, Molecular Cell 74, 1278–1290 June 20, 2019 ª 2019 The Author(s). Published by Elsevier Inc. https://doi.org/10.1016/j.molcel.2019.03.040 Molecular Cell Article METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation Luca Pandolfini,1,9 Isaia Barbieri,1,2,9 Andrew J. Bannister,1 Alan Hendrick,3 Byron Andrews,3 Natalie Webster,3 Pierre Murat,4,7 Pia Mach,1 Rossella Brandi,5 Samuel C. Robson,1,8 Valentina Migliori,1 Andrej Alendar,1 Mara d’Onofrio,5,6 Shankar Balasubramanian,4
    [Show full text]
  • Análise Integrativa De Perfis Transcricionais De Pacientes Com
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Ribeirão Preto – 2012 ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de Concentração: Genética Orientador: Prof. Dr. Eduardo Antonio Donadi Co-orientador: Prof. Dr. Geraldo A. S. Passos Ribeirão Preto – 2012 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Evangelista, Adriane Feijó Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas. Ribeirão Preto, 2012 192p. Tese de Doutorado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de Concentração: Genética. Orientador: Donadi, Eduardo Antonio Co-orientador: Passos, Geraldo A. 1. Expressão gênica – microarrays 2. Análise bioinformática por module maps 3. Diabetes mellitus tipo 1 4. Diabetes mellitus tipo 2 5. Diabetes mellitus gestacional FOLHA DE APROVAÇÃO ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas.
    [Show full text]
  • Editing and Chemical Modifications on Non-Coding Rnas in Cancer
    International Journal of Molecular Sciences Review Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance Ligia I. Torsin 1,† , George E. D. Petrescu 2,3,† , Alexandru A. Sabo 4, Baoqing Chen 5,6, Felix M. Brehar 2,3, Mihnea P. Dragomir 7,* and George A. Calin 8,9,* 1 Department of Anesthesiology and Critical Care, Elias Clinical Emergency Hospital, 011461 Bucharest, Romania; [email protected] 2 Department of Neurosurgery, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; [email protected] (G.E.D.P.); [email protected] (F.M.B.) 3 Department of Neurosurgery, Bagdasar-Arseni Clinical Emergency Hospital, 041915 Bucharest, Romania 4 Zentrum für Kinder, Jugend und Frauenmedizin, Pediatrics 2 (General and Special Pediatrics), Klinikum Stuttgart, Olgahospital, 70174 Stuttgart, Germany; [email protected] 5 State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; [email protected] 6 Guangdong Esophageal Cancer Research Institute, Guangzhou 510060, China 7 Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany 8 Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 9 Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA * Correspondence: [email protected] or [email protected] (M.P.D.); [email protected] (G.A.C.); Tel.: +40-254-219-493 (M.P.D.); +1-713-792-5461 (G.A.C.) † These authors contributed equally to this work.
    [Show full text]
  • Quantitative Trait Loci Mapping of Macrophage Atherogenic Phenotypes
    QUANTITATIVE TRAIT LOCI MAPPING OF MACROPHAGE ATHEROGENIC PHENOTYPES BRIAN RITCHEY Bachelor of Science Biochemistry John Carroll University May 2009 submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY December 2017 We hereby approve this thesis/dissertation for Brian Ritchey Candidate for the Doctor of Philosophy in Clinical-Bioanalytical Chemistry degree for the Department of Chemistry and the CLEVELAND STATE UNIVERSITY College of Graduate Studies by ______________________________ Date: _________ Dissertation Chairperson, Johnathan D. Smith, PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, David J. Anderson, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Baochuan Guo, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Stanley L. Hazen, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Renliang Zhang, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Aimin Zhou, PhD Department of Chemistry, Cleveland State University Date of Defense: October 23, 2017 DEDICATION I dedicate this work to my entire family. In particular, my brother Greg Ritchey, and most especially my father Dr. Michael Ritchey, without whose support none of this work would be possible. I am forever grateful to you for your devotion to me and our family. You are an eternal inspiration that will fuel me for the remainder of my life. I am extraordinarily lucky to have grown up in the family I did, which I will never forget.
    [Show full text]
  • 27Th Trna Conference-Abstractsbook-3
    P1.1 The protein-only RNase P PRORP1 interacts with the nuclease MNU2 in Arabidopsis mitochondria G. Bonnard, M. Arrivé, A. Bouchoucha, A. Gobert, C. Schelcher, F. Waltz, P. Giegé Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France The essential endonuclease activity that removes 5’ leader sequences from transfer RNA precursors is called RNase P. While ribonucleoprotein RNase P enzymes containing a ribozyme are found in all domains of life, another type of RNase P called “PRORP”, for “PROtein-only RNase P”, only composed of protein occurs in a wide variety of eukaryotes, in organelles and the nucleus. Although PRORP proteins function as single subunit enzymes in vitro, we find that PRORP1 occurs in protein complexes and is present in polysome fractions in Arabidopsis mitochondria. The analysis of immuno- precipitated protein complexes identifies proteins involved in mitochondrial gene expression processes. In particular, direct interaction is established between PRORP1 and MNU2 another mitochondrial nuclease involved in RNA 5’ processing. A specific domain of MNU2 and a conserved signature of PRORP1 are found to be directly accountable for this protein interaction. Altogether, results reveal the existence of an RNA 5’ maturation complex in Arabidopsis mitochondria and suggest that PRORP proteins might cooperate with other gene expression regulators for RNA maturation in vivo. 111 P1.2 CytoRP, a cytosolic RNase P to target TLS-RNA phytoviruses 1 1 2 1 A. Gobert , Y. Quan , I. Jupin , P. Giegé 1Institut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, Strasbourg, France 1Institut Jacques Monod, CNRS, Université Paris Diderot, Paris, France In plants, PRORP enzymes are responsible for RNase P activity that involves the removal of the 5’ extremity of tRNA precursors.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Receptor Signaling Through Osteoclast-Associated Monocyte
    Downloaded from http://www.jimmunol.org/ by guest on September 29, 2021 is online at: average * The Journal of Immunology The Journal of Immunology , 20 of which you can access for free at: 2015; 194:3169-3179; Prepublished online 27 from submission to initial decision 4 weeks from acceptance to publication February 2015; doi: 10.4049/jimmunol.1402800 http://www.jimmunol.org/content/194/7/3169 Collagen Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through Osteoclast-Associated Receptor Heidi S. Schultz, Louise M. Nitze, Louise H. Zeuthen, Pernille Keller, Albrecht Gruhler, Jesper Pass, Jianhe Chen, Li Guo, Andrew J. Fleetwood, John A. Hamilton, Martin W. Berchtold and Svetlana Panina J Immunol cites 43 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice option Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Freely available online through http://www.jimmunol.org/content/suppl/2015/02/27/jimmunol.140280 0.DCSupplemental This article http://www.jimmunol.org/content/194/7/3169.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Author Choice Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • SETD3 Protein Is the Actin-Specific Histidine N-Methyltransferase
    RESEARCH ARTICLE SETD3 protein is the actin-specific histidine N-methyltransferase Sebastian Kwiatkowski1†, Agnieszka K Seliga1†, Didier Vertommen2, Marianna Terreri1, Takao Ishikawa3, Iwona Grabowska4, Marcel Tiebe5,6, Aurelio A Teleman5,6, Adam K Jagielski1, Maria Veiga-da-Cunha7*, Jakub Drozak1* 1Department of Metabolic Regulation, Faculty of Biology, University of Warsaw, Warsaw, Poland; 2Protein Phosphorylation Unit, de Duve Institute, Universite´ Catholique de Louvain, Brussels, Belgium; 3Department of Molecular Biology, Faculty of Biology, University of Warsaw, Warsaw, Poland; 4Department of Cytology, Faculty of Biology, University of Warsaw, Warsaw, Poland; 5German Cancer Research Center (DKFZ), Heidelberg, Germany; 6Heidelberg University, Heidelberg, Germany; 7Metabolic Research Unit, de Duve Institute, Universite´ Catholique de Louvain, Brussels, Belgium Abstract Protein histidine methylation is a rare post-translational modification of unknown biochemical importance. In vertebrates, only a few methylhistidine-containing proteins have been reported, including b-actin as an essential example. The evolutionary conserved methylation of b- actin H73 is catalyzed by an as yet unknown histidine N-methyltransferase. We report here that the protein SETD3 is the actin-specific histidine N-methyltransferase. In vitro, recombinant rat and human SETD3 methylated b-actin at H73. Knocking-out SETD3 in both human HAP1 cells and in Drosophila melanogaster resulted in the absence of methylation at b-actin H73 in vivo, whereas b- actin from wildtype cells or flies was > 90% methylated. As a consequence, we show that Setd3- *For correspondence: deficient HAP1 cells have less cellular F-actin and an increased glycolytic phenotype. In conclusion, [email protected] (MV–C); by identifying SETD3 as the actin-specific histidine N-methyltransferase, our work pioneers new [email protected] (JD) research into the possible role of this modification in health and disease and questions the †These authors contributed substrate specificity of SET-domain-containing enzymes.
    [Show full text]
  • Transcriptional Profile of Human Anti-Inflamatory Macrophages Under Homeostatic, Activating and Pathological Conditions
    UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE CIENCIAS QUÍMICAS Departamento de Bioquímica y Biología Molecular I TESIS DOCTORAL Transcriptional profile of human anti-inflamatory macrophages under homeostatic, activating and pathological conditions Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas MEMORIA PARA OPTAR AL GRADO DE DOCTOR PRESENTADA POR Víctor Delgado Cuevas Directores María Marta Escribese Alonso Ángel Luís Corbí López Madrid, 2017 © Víctor Delgado Cuevas, 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Víctor Delgado Cuevas Tesis Doctoral Madrid 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Este trabajo ha sido realizado por Víctor Delgado Cuevas para optar al grado de Doctor en el Centro de Investigaciones Biológicas de Madrid (CSIC), bajo la dirección de la Dra. María Marta Escribese Alonso y el Dr. Ángel Luís Corbí López Fdo. Dra. María Marta Escribese
    [Show full text]
  • Atlas Journal
    Atlas of Genetics and Cytogenetics in Oncology and Haematology Home Genes Leukemias Solid Tumours Cancer-Prone Deep Insight Portal Teaching X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA Atlas Journal Atlas Journal versus Atlas Database: the accumulation of the issues of the Journal constitutes the body of the Database/Text-Book. TABLE OF CONTENTS Volume 11, Number 2, Apr-Jun 2007 Previous Issue / Next Issue Genes BOK (BCL2-related ovarian killer) (2q37.3). Alexander G Yakovlev. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (2): 119-123. [Full Text] [PDF] URL : http://AtlasGeneticsOncology.org/Genes/BOKID824ch2q37.html BIRC6 (Baculoviral IAP repeat-containing 6) (2p22). Christian Pohl, Stefan Jentsch. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (2): 124-129. [Full Text] [PDF] URL : http://AtlasGeneticsOncology.org/Genes/BIRC6ID798ch2p22.html AKAP12 (A kinase (PRKA) anchor protein 1) (6q25). Irwin H Gelman. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (2): 130-136. [Full Text] [PDF] URL : http://AtlasGeneticsOncology.org/Genes/AKAP12ID607ch6q25.html TRIM 24 (tripartite motif-containing 24) (7q34). Jean Loup Huret. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (2): 137-141. [Full Text] [PDF] Atlas Genet Cytogenet Oncol Haematol 2007; 2 - I - URL : http://AtlasGeneticsOncology.org/Genes/TRIM24ID504ch7q34.html RUNX 2 (Runt-related transcription factor 2) (6p21). Athanasios G Papavassiliou, Panos Ziros. Atlas Genet Cytogenet Oncol Haematol 2007; 11 (2): 142-147. [Full Text] [PDF] URL : http://AtlasGeneticsOncology.org/Genes/RUNX2ID42183ch6p21.html PTPRG (protein tyrosine phosphatase, receptor type, G) (3p14.2). Cornelis P Tensen, Remco van Doorn.
    [Show full text]
  • Hypomodified Trna in Evolutionarily Distant Yeasts Can Trigger Rapid Trna Decay to Activate
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.29.123083; this version posted May 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 2 3 Hypomodified tRNA in evolutionarily distant yeasts can trigger rapid tRNA decay to activate 4 the general amino acid control response, but with different consequences 5 6 Thareendra De Zoysa, Eric M. Phizicky1 7 Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester School 8 of Medicine, Rochester, NY, USA 14642 9 10 Address correspondence to: 11 Eric M. Phizicky 12 Department of Biochemistry and Biophysics 13 University of Rochester School of Medicine 14 601 Elmwood Avenue 15 Rochester, NY 14642 16 Phone: 585-275-7268 17 Email: [email protected] 18 Running Title: Rapid tRNA decay and general amino acid control in divergent yeasts 19 Key words: S. pombe/S. cerevisiae/Trm8/m7G/rapid tRNA decay/general amino acid control De Zoysa 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.05.29.123083; this version posted May 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 20 Abstract 21 22 All tRNAs are extensively modified, and modification deficiency often results in growth defects 23 in the budding yeast Saccharomyces cerevisiae and neurological or other disorders in humans.
    [Show full text]
  • Roles of Elongator Dependent Trna Modification Pathways In
    G C A T T A C G G C A T genes Review Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer Harmen Hawer 1,†, Alexander Hammermeister 1,† , Keerthiraju Ethiraju Ravichandran 2,3,† , Sebastian Glatt 2 , Raffael Schaffrath 1,* and Roland Klassen 1,* 1 Institut für Biologie, FG Mikrobiologie, Universität Kassel, Heirich-Plett-Str. 40, 34132 Kassel, Germany; [email protected] (H.H.); [email protected] (A.H.) 2 Max Planck Research Group at the Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] (K.E.R.); [email protected] (S.G.) 3 Postgraduate School of Molecular Medicine, 02-091 Warsaw, Poland * Correspondence: [email protected] (R.S.); [email protected] (R.K.); Tel.: +49-561-804-4175 (R.S.); +49-561-804-4340 (R.K.) † Equal co-author contributions. Received: 30 November 2018; Accepted: 20 December 2018; Published: 28 December 2018 Abstract: Transfer RNA (tRNA) is subject to a multitude of posttranscriptional modifications which can profoundly impact its functionality as the essential adaptor molecule in messenger RNA (mRNA) translation. Therefore, dynamic regulation of tRNA modification in response to environmental changes can tune the efficiency of gene expression in concert with the emerging epitranscriptomic mRNA regulators. Several of the tRNA modifications are required to prevent human diseases and are particularly important for proper development and generation of neurons. In addition to the positive role of different tRNA modifications in prevention of neurodegeneration, certain cancer types upregulate tRNA modification genes to sustain cancer cell gene expression and metastasis.
    [Show full text]